AU6714396A - Methods and compositions for treating cell proliferative disorders - Google Patents
Methods and compositions for treating cell proliferative disordersInfo
- Publication number
- AU6714396A AU6714396A AU67143/96A AU6714396A AU6714396A AU 6714396 A AU6714396 A AU 6714396A AU 67143/96 A AU67143/96 A AU 67143/96A AU 6714396 A AU6714396 A AU 6714396A AU 6714396 A AU6714396 A AU 6714396A
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- methods
- cell proliferative
- proliferative disorders
- treating cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title 1
- 230000002062 proliferating effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50900295A | 1995-07-28 | 1995-07-28 | |
US509002 | 1995-07-28 | ||
PCT/US1996/012381 WO1997004761A1 (en) | 1995-07-28 | 1996-07-29 | Methods and compositions for treating cell proliferative disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6714396A true AU6714396A (en) | 1997-02-26 |
Family
ID=24024929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU67143/96A Abandoned AU6714396A (en) | 1995-07-28 | 1996-07-29 | Methods and compositions for treating cell proliferative disorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6714396A (en) |
WO (1) | WO1997004761A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6025365A (en) * | 1997-03-25 | 2000-02-15 | Arch Development Corp. | Chelerythrine and radiation combined tumor therapy |
WO1999010004A2 (en) * | 1997-08-29 | 1999-03-04 | Ontogeny, Inc. | Regulation of muscle tissues by hedgehog-like polypeptides, and formulations and uses related thereto |
IL122591A0 (en) * | 1997-12-14 | 1998-06-15 | Arad Dorit | Pharmaceutical compositions comprising cystein protease inhibitors |
CA2324426A1 (en) | 1998-02-11 | 1999-08-19 | Douglas V. Faller | Compositions and methods for the treatment of cystic fibrosis |
EP1057484A4 (en) * | 1998-02-23 | 2002-11-20 | Sagami Chem Res | INHIBITORS OF CELL DEATH |
US6402748B1 (en) | 1998-09-23 | 2002-06-11 | Sherwood Services Ag | Electrosurgical device having a dielectrical seal |
CA2396704A1 (en) * | 2000-01-31 | 2001-08-09 | Yeda Research And Development Co. Ltd. | Polycyclic dianthraquinones as anti-cancer and anti-angiogenic agents |
EP1311262A4 (en) * | 2000-07-28 | 2005-06-01 | Cancer Rec Tech Ltd | Cancer treatment by combination therapy |
GB0121285D0 (en) | 2001-09-03 | 2001-10-24 | Cancer Res Ventures Ltd | Anti-cancer combinations |
GB2386836B (en) | 2002-03-22 | 2006-07-26 | Cancer Res Ventures Ltd | Anti-cancer combinations |
GB2394658A (en) | 2002-11-01 | 2004-05-05 | Cancer Rec Tech Ltd | Oral anti-cancer composition |
WO2005112912A1 (en) * | 2004-04-24 | 2005-12-01 | Sang-Hee Kim | Immunomoduating agent, anti-cancer agent and health food containing monoacetyldiacylglycerol derivatives |
EP1951255A1 (en) | 2005-11-14 | 2008-08-06 | Universität Zürich | Staurosporine derivatives for use in alveolar rhabdomyosarcoma |
EP2014651A1 (en) * | 2007-07-12 | 2009-01-14 | Exonhit Therapeutics SA | Compounds and methods for modulating Rho GTPases |
WO2011038224A1 (en) | 2009-09-24 | 2011-03-31 | Trustees Of Boston University | Methods for treating viral disorders |
US8618068B2 (en) | 2009-12-08 | 2013-12-31 | Trustees Of Boston University | Methods and low dose regimens for treating red blood cell disorders |
US20110245154A1 (en) | 2010-03-11 | 2011-10-06 | Hemaquest Pharmaceuticals, Inc. | Methods and Compositions for Treating Viral or Virally-Induced Conditions |
CN103429235A (en) * | 2010-12-15 | 2013-12-04 | 赖鸿政 | Compounds and uses thereof for the treatment of cancer |
US9561245B2 (en) | 2012-09-06 | 2017-02-07 | The Board Of Regents Of The University Of Texas System | Combination treatments for melanoma |
US9572828B2 (en) | 2013-07-18 | 2017-02-21 | The Board Of Regents Of The University Of Texas System | Treatment for melanoma |
US10363263B2 (en) | 2015-11-04 | 2019-07-30 | Prescient Pharma, Llc | Anti-aging compositions and methods for using same |
US20220226322A1 (en) | 2019-05-31 | 2022-07-21 | Viracta Subsidiary, Inc. | Methods of treating virally associated cancers with histone deacetylase inhibitors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816462A (en) * | 1982-05-18 | 1989-03-28 | Nowicky Wassili | Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds |
JPS60178815A (en) * | 1984-02-24 | 1985-09-12 | Rikagaku Kenkyusho | Carcinostatic agent |
JPS62155284A (en) * | 1985-12-27 | 1987-07-10 | Kyowa Hakko Kogyo Co Ltd | Physiologically active substance k-252 derivative |
-
1996
- 1996-07-29 AU AU67143/96A patent/AU6714396A/en not_active Abandoned
- 1996-07-29 WO PCT/US1996/012381 patent/WO1997004761A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1997004761A1 (en) | 1997-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4655296A (en) | Compositions and methods for treating tumor cells | |
AU6714396A (en) | Methods and compositions for treating cell proliferative disorders | |
IL112921A0 (en) | Methods and compositions for inhibiting cell proliferative disorders | |
AU5439996A (en) | Compositions and methods for treating pain | |
AU6694596A (en) | Method and composition for treating asthma | |
AU5387796A (en) | Method and compositions for treating impotence | |
AU3512295A (en) | Composition and method for treating hair | |
AU2593900A (en) | Composition and method for treating glaucoma | |
AU1296099A (en) | Methods and compositions for treating dermatoses | |
AU7379896A (en) | Method and apparatus for improving the function of sensory cells | |
AU1128297A (en) | Composition for treating pain | |
AU5268696A (en) | Novel compounds and methods for therapy | |
AU9214398A (en) | Compositions and methods for treating water | |
AU8693098A (en) | Compositions and methods for treating diabetes | |
AU1969997A (en) | Methods and apparatus for dispensing compositions | |
AU4139196A (en) | Method and composition for antiviral therapy | |
AU2113295A (en) | Novel compositions and methods for water treatment | |
AU5979496A (en) | Composition and methods for losing weight | |
AU2701195A (en) | Methods for treating cancer and other cell proliferative diseases | |
AU2808997A (en) | Method for treating inflammation | |
AU2259897A (en) | Methods and compositions for the simultaneous control of rootdiseases | |
AU5301296A (en) | Methods and compositions for regulating fadd | |
AU3768795A (en) | Method and compositions for hair treatment | |
AU4859399A (en) | Compositions and methods for treating papillomavirus-infected cells | |
AU5333298A (en) | Compositions and methods for tumour therapy |